Abivax (ABVX) EBT Margin: 2022-2025
Historic EBT Margin for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to 753.06%.
- Abivax's EBT Margin rose 12581757.00% to 753.06% in Q2 2025 from the same period last year, while for Jun 2025 it was 1,163.94%, marking a year-over-year decrease of 62680.00%. This contributed to the annual value of -1,415.71% for FY2024, which is 178143.00% up from last year.
- Abivax's EBT Margin amounted to 753.06% in Q2 2025, which was down 32.89% from 1,122.13% recorded in Q1 2025.
- In the past 5 years, Abivax's EBT Margin registered a high of 1,122.13% during Q1 2025, and its lowest value of -125,064.52% during Q2 2024.
- In the last 3 years, Abivax's EBT Margin had a median value of 376.74% in 2023 and averaged -20,374.15%.
- As far as peak fluctuations go, Abivax's EBT Margin plummeted by 40bps in 2024, and later spiked by 12,581,757bps in 2025.
- Quarterly analysis of 4 years shows Abivax's EBT Margin stood at -1,408.70% in 2022, then surged by 140,912bps to 0.42% in 2023, then plummeted by 40bps to 0.02% in 2024, then soared by 12,581,757bps to 753.06% in 2025.
- Its EBT Margin stands at 753.06% for Q2 2025, versus 1,122.13% for Q1 2025 and 0.02% for Q4 2024.